Cargando…
Perspectives of Methotrexate-Based Radioagents for Application in Nuclear Medicine
[Image: see text] Methotrexate is a gold standard among disease modifying antirheumatic drugs and is also extensively used clinically in combination with oncological therapies. Thus, it is not surprising that nuclear medicine found an interest in methotrexate in the search for diagnostic and therape...
Autores principales: | Halik, Paweł Krzysztof, Koźmiński, Przemysław, Gniazdowska, Ewa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7788572/ https://www.ncbi.nlm.nih.gov/pubmed/33251808 http://dx.doi.org/10.1021/acs.molpharmaceut.0c00740 |
Ejemplares similares
-
Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers
por: Koźmiński, Przemysław, et al.
Publicado: (2020) -
Common Shortcomings in Study on Radiopharmaceutical Design Research: A Case Study of (99m)Tc-Labelled Methotrexate
por: Koźmiński, Przemysław, et al.
Publicado: (2021) -
The Role of VEGF Receptors as Molecular Target in Nuclear Medicine for Cancer Diagnosis and Combination Therapy
por: Masłowska, Katarzyna, et al.
Publicado: (2021) -
In Vitro Biological Evaluation of Aprepitant Based (177)Lu-Radioconjugates
por: Halik, Paweł K., et al.
Publicado: (2022) -
Novel NK1R-Targeted (68)Ga-/(177)Lu-Radioconjugates with Potential Application against Glioblastoma Multiforme: Preliminary Exploration of Structure–Activity Relationships
por: Matalińska, Joanna, et al.
Publicado: (2022)